SAN CLEMENTE, Calif., Feb 25 -- BIOLASE Technology, Inc. has received clearance from the Food and Drug Administration for its patented Waterlase technology for several new bone, periodontal and soft tissue procedures. The new clearance paves the way for dentists to perform additional procedures with the Waterlase, which is the first laser to receive clearance for these new bone, periodontal and general soft tissue surgical indications:
The clearance also covers soft tissue curettage for post extraction tooth socket. According to the ADA report more than 30 million tooth extractions are performed per year, which can now be treated with the Waterlase.
For further information, visit www.biolase.com